Cor Vasa 2006, 48(5):186-190 | DOI: 10.33678/cor.2006.057

Cellular therapy of coronary heart disease: a summary of state of the art, limitations and prospects. Part One. Introduction, techniques of myocardial cell transplantation, skeletal myoblasts.

Martin Pěnička1,*, Petr Widimský1, Tomasz Siminiak2, Otto Lang3, Karol Čurila1, Kateřina Hesová1
1 III. interní-kardiologická klinika, Kardiocentrum
3 Klinika nukleární medicíny, Fakultní nemocnice Královské Vinohrady a 3. lékařská fakulta Univerzity Karlovy, Praha, Česká republika
2 Kardiologická klinika, Lékařská fakulta, Krajská nemocnice, Poznaň, Polsko

The review article examines the state of the art in cellular therapy of coronary heart disease and options of myocardial regeneration. The article summarizes data from experimental and pilot clinical studies, discusses in detail the limitations of cellular therapy, and provides an outline of future developments. The paper is divided into two parts. Part one provides background information and addresses the issue of cell transplantation into the myocardium and skeletal myoblasts. Part two covers the issue of stem cells and prospects of cellular therapy.

Keywords: Myocardial regeneration; Stem cells; Myoblasts; Coronary heart disease

Published: May 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pěnička M, Widimský P, Siminiak T, Lang O, Čurila K, Hesová K. Cellular therapy of coronary heart disease: a summary of state of the art, limitations and prospects. Part One. Introduction, techniques of myocardial cell transplantation, skeletal myoblasts. Cor Vasa. 2006;48(5):186-190. doi: 10.33678/cor.2006.057.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cohn JN, Bristow MR, Chien KR, et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 1997; 95:766-70. Go to original source... Go to PubMed...
    2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990;81:1161-72. Go to original source... Go to PubMed...
    3. St John Sutton M, Pfeffer MA, Moye L, et al. for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994;89:68-75. Go to original source... Go to PubMed...
    4. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-7. Go to original source... Go to PubMed...
    5. Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res 2002;91:1092-102. Go to original source... Go to PubMed...
    6. Wollert KC, Drexler H. Clinical applications of stem cells to heart. Circ Res 2005;96:151-63. Go to original source... Go to PubMed...
    7. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-40. Go to original source... Go to PubMed...
    8. Lev S, Kehat I, Gepstein L Differentiation pathways in human embryonic stem cell-derived cardiomyocytes. Ann NY Acad Sci 2005;1047:50-65. Go to original source... Go to PubMed...
    9. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4: 929-33. Go to original source... Go to PubMed...
    10. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-80. Go to original source... Go to PubMed...
    11. Smits PC, Van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003;42:2063-9. Go to original source... Go to PubMed...
    12. Winitsky SO, Gopal TV, Hassanzadeh S, et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. Plos Biology 2005;3:e87. Go to original source... Go to PubMed...
    13. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-6. Go to original source... Go to PubMed...
    14. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5. Go to original source... Go to PubMed...
    15. Tomita S, Li R-K, Weisel RD, Micjke DAG, Jia ZQ. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100 (Suppl): II247-II256. Go to original source... Go to PubMed...
    16. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123:1132-40. Go to original source... Go to PubMed...
    17. Badorff CC, Brandes RP, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-32. Go to original source... Go to PubMed...
    18. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402. Go to original source... Go to PubMed...
    19. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697-705. Go to original source... Go to PubMed...
    20. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002;73:1919-25. Go to original source... Go to PubMed...
    21. Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005;111:150-6. Go to original source... Go to PubMed...
    22. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8. Go to original source... Go to PubMed...
    23. Dawn B, Stein AB, Urbanek K, et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 2005;102:3766-71. Go to original source... Go to PubMed...
    24. Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 2005; 102:8692-7. Go to original source... Go to PubMed...
    25. Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005;102: 8966-71. Go to original source... Go to PubMed...
    26. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005;85:1373-416. Go to original source... Go to PubMed...
    27. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21. Go to original source... Go to PubMed...
    28. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8. Go to original source... Go to PubMed...
    29. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003;361:45-6. Go to original source... Go to PubMed...
    30. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart disease. Circulation 2003;107:2294-302. Go to original source... Go to PubMed...
    31. Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005;26:1188-95. Go to original source... Go to PubMed...
    32. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial. Lancet 2004;363:751-6. Go to original source... Go to PubMed...
    33. Ince H, Petzsch M, Kleine DH, et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction. Final 1-year results of the Front-Integrated Revascularization and Stem cell Liberation IN Evolving Acute Myocardial Infarction by granulocyte colony-stimulating factor (FIRSTLINE-AMI) trial. Circulation 2005;112 (Suppl I):I-73-I-80. Go to original source... Go to PubMed...
    34. Saito T, Kuang JQ, Lin CC, Chiu RC. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg 2003;126:114-23. Go to original source... Go to PubMed...
    35. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-9. Go to original source... Go to PubMed...
    36. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell traficking is regulated by hypoxic gradients through hif-1 induction of sdf-1. Nat Med 2004;10:858-64. Go to original source... Go to PubMed...
    37. Chavakis E, Aicher A, Heeschen C, et al. Role of b2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 2005;201:63-72. Go to original source... Go to PubMed...
    38. De Falco E, Porcelli D, Torella AR, et al. Sdf-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004;104:3472-82. Go to original source... Go to PubMed...
    39. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999;144:1113-22. Go to original source... Go to PubMed...
    40. Tse HF, Kwong YM, Chan JKF, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361:47-9. Go to original source... Go to PubMed...
    41. Fuchs S, Satler L, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease. J Am Coll Cardiol 2003;41:1721-4. Go to original source... Go to PubMed...
    42. Dowell JD, Rubart M, Pasumarthi KBS, et al. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003;58:333-47. Go to original source... Go to PubMed...
    43. Menache P. Skeletal muscle satellite cells transplantation. Cardiovasc Res 2003;58:3517. Go to original source... Go to PubMed...
    44. Bouchentouf M, Benabdallah BF, Tremblay JP. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 2004;77:1349-56. Go to original source... Go to PubMed...
    45. Ghostine S, Carrion C, Souza LC, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002;106 (12 Suppl 1):I131-I136. Go to original source... Go to PubMed...
    46. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemiadamaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88. Go to original source... Go to PubMed...
    47. Menache P. Cell transplantation in myocardium. Ann Thorac Surg 2003;75:S20-S8. Go to original source... Go to PubMed...
    48. Siminiak T, Kalawski R, Fiszer D, et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004;148: 531-7. Go to original source... Go to PubMed...
    49. Menache P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83. Go to original source... Go to PubMed...
    50. Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;112:1748-55. Go to original source... Go to PubMed...
    51. Serruys PW. Pilotní zkušenosti s perkutánní transplantací kosterních myoblastů u chronické ischemické choroby srdeční. Přednáška na Workshop on Bone Marrow Stem Cells. Capri, Italy 2003.
    52. Herreros J, Prósper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003;24:2012-20. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes